Skip to main content
Clinical Trials/ACTRN12611000182998
ACTRN12611000182998
Active, not recruiting
Phase 2

A double blind randomized clinical trial to evaluate the effect of oral allopurinol on the prevention of post ERCP pancreatitis

Mohammad Abbasinazari0 sites500 target enrollmentFebruary 15, 2011

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Mohammad Abbasinazari
Enrollment
500
Status
Active, not recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 15, 2011
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Mohammad Abbasinazari

Eligibility Criteria

Inclusion Criteria

  • all patients above 20 years old undergoing ERCP in the gastrointestinal and liver diseases ward of Talighani hospital (Tehran, Iran) with informed consent

Exclusion Criteria

  • patients with renal failure or patients with bone marrow suppression ,those who had developed acute pancreatitis during 2 weeks before ERCP, pregnant women, patient who took azathioprine and those who didn’t agree to participate in the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials